Persian Traditional Medicine in Treatment of Ulcerative Colitis: a Case Report

Document Type : Case report


1 Department of Persian Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Health Management and Social Development Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

3 Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran


Background and objectives: Ulcerative colitis (UC) is a chronic inflammatory bowel disease. Herbal medicines such as Persicaria bistorta, Pistacia lentiscus, Punica granatum, and Myrtus communis manifesting a variety of pharmacological properties and effects, have been widely implicated in the treatment of UC. We report a case of UC in a 42-year-old male patient. Methods: The patient presented frequent passage of bloody stool, severe cramping, and abdominal pain. This was accompanied by fatigue, excessive mucus, and pus in the stool. He had a 12 years prehistoric diagnosis of ulcerative colitis and received conventional therapy, which yielded no improvement in the symptoms. His regimen was then switched to the Persian traditional treatment employing the “Sahj” formula (including Persicaria bistorta, Pistacia lentiscus, Boswellia frereana, Punica granatum, and Myrtus communis) for 4 months. Results: After 18 days of traditional therapy with “Sahj” tablet, there was a significant improvement in his UC symptoms as evidenced in the increased frequency of his bowel movements (twice daily), absence of bloating, cramping, or abdominal pain and a normal bloodless stool. A colonoscopy report and digital rectal examination 4 months post-treatment, revealed a normal perianal area, cecum, and terminal ileum. Conclusion: The results suggest that the Persian traditional “Sahj” medicine possesses pharmacological properties that render it effective in the treatment of UC and mucosal diseases. However, further clinical trials are needed to evaluate and confirm the efficacy and safety of “Sahj” therapy.


Main Subjects

[1] Antonelli E, Villanacci V, Bassotti G. Novel oral-targeted therapies for mucosal healing in ulcerative colitis. World J Gastroenterol. 2018; 24(47): 5322-5330.
[2] Naganuma M. Treatment with Indigo naturalis for inflammatory bowel disease and other immune diseases. Immunol Med. 2019; 42(1): 16-21.
[3] César B, Lyra AC, Rocha R, Santana GO. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World J Gastroenterol. 2014; 20(28): 9458-9467.
[4] Naganuma M, Mizuno S, Nanki K, Sugimoto S. Recent trends and future directions for the medical treatment of ulcerative colitis. Clin J Gastroenterol. 2016; 9(6): 329-336.
[5] D’Inca R, Garribba AT, Vettorato MG, Martin A, Martines D, Di Leo V, Buda A, Sturniolo GC. Use of alternative and complementary therapies by inflammatory bowel disease patients in an Italian tertiary referral center. Dig Liver Dis. 2007; 39(6): 524-529.
[6] Ke F, Yadav PK, Ju LZ. Herbal medicine in the treatment of ulcerative colitis. Saudi J Gastroenterol. 2012; 18(1): 3-10.
[7] Sałaga M, Zatorski H, Sobczak M, Chen C, Fichna J. Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review. Curr Treat Options Oncol. 2014; 15(3): 405-420.
[8] Lal UR, SinghIP. Review and implications of traditional Indian medicine for inflammatory bowel disease. [Accessed 2020]. Available from
[9] Sharifi Darani N, Cooper GM, Alizadeh Vaghasloo M. Introduction to the concept of crisis in diseases. Trad Integr Med. 2019; 4(4): 165-169.
[10] Mosleh G, Nimrouzi M, Badr P, Abolhasanzadeh Z, Azadi A, Mohagheghzadeh A. The approach of traditional Persian medicine to treatment of anal fissure. Trad Integr Med. 2019; 4(2): 78-83.
[11] Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee BH, Lomer MC, Parkes GC, Selinger C, Barrett KJ.  British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019; 68(S3): 1-106.
[12] Moradi Z, Besharat M, Ghorbanifar Z, Parsa-Yekta Z, Masroorchehr MR. Intestinal ulcer: review of diagnosis and treatment in persian medicine. Sch J App Med Sci. 2015; 3(1): 460-466.
[13] Aghili Alavi Khorasani Shirazi MH. Makhzan-al-advieh. Kanpur: Bhagwan Dial, 1913.
[14] Papada E, Forbes A, Amerikanou C, Torović L, Kalogeropoulos N, Tzavara C, Triantafillidis JK, Kaliora AC. Antioxidative efficacy of a Pistacia lentiscus supplement and its effect on the plasma amino acid profile in inflammatory bowel disease: a randomised, double-blind, placebo-controlled trial. Nutrients. 2018; 10(11): 1-17.
[15] Article R, Ansari SH, Siddiqui AN. Pistacia lentiscus: a review on phytochemistry and pharmacological properties. Int J Pharm Pharm Sci. 2012; 4(4): 16-20.
[16] Asakura H, Kitahora T. Antioxidants and polyphenols in inflammatory bowel disease: ulcerative colitis and Crohn disease. 2nd ed. Academic Press, 2018.
[17] Watson R, Preedy V, Zibadi SH. Polyphenols in human health and disease. Academic Press, 2013.
[18] Lu Y, Zamora-Ros R, Chan S, Cross AJ, Ward H, Jakszyn P, Luben R, Opstelten JL, Oldenburg B, Hallmans G, Karling P, Grip O, Key T, Bergmann MM, Boeing H, Overvad K, Palli D, Masala G, Khaw KT, Racine A, Carbonnel F, Boutron-Ruault MC, Andersen V, Olsen A, Tjonneland A, Kaaks R, Tumino R, Trichopoulou A, Scalbert A, Riboli E, Hart AR. Dietary polyphenols in the aetiology of Crohn's disease and ulcerative colitis-a multicenter European prospective cohort study (EPIC). Inflamm Bowel Dis. 2017; 23(12): 2072-2082.
[19] Triantafyllidi A, Xanthos T, Papalois A, Triantafillidis JK. Herbal and plant therapy in patients with inflammatory bowel disease. Ann Gastroenterol. 2015; 28(2): 210-220.
[20] Iram F, Khan SA, Husain A. Phytochemistry and potential therapeutic actions of boswellic acids: a mini-review. Asian Pac J Trop Biomed. 2017; 7(6): 513-523.
[21] Papada E, Gioxari A, Amerikanou C, Forbes A, Tzavara C, Smyrnioudis I, Kaliora AC. Regulation of faecal biomarkers in inflammatory bowel disease patients treated with oral mastiha (Pistacia lentiscus) supplement: a double-blind and placebo-controlled randomised trial. Phytother Res. 2019; 33(2): 360-369.
[22] Heydarpour F, Abasabadi M, Shahpiri Z, Vaziri S, Nazari H, Najafi F, Mirzaei M, Farzaei M. Medicinal plant and their bioactive phytochemicals in the treatment of recurrent aphthous ulcers: a review of clinical trials. Pharmacogn Rev. 2018; 12(23): 27-39.
[23] Sisay M, Gashaw T. Ethnobotanical, ethnopharmacological, and phytochemical studies of Myrtus communis Linn: a popular herb in Unani system of medicine. J Evid Based Complement Altern Med. 2017; 22(4): 1035-1043.
[24] Hosseinkhani A, Montaseri H, Mohagheghzadeh A, Seradj H, Sodaifi M. Armenian bole: a historical medicinal clay. Pharm Hist. 2014; 44 (4): 98-100.